When the body is burdened with disease, Vitamin C may be low or deficient. Intravenous Vitamin C (IV C) has been used in cancer care to address ascorbate deficiency that could favourably affect clinical parameters such as inflammation, fatigue, and overall quality of life. Intravenous administration of Vitamin C bypasses the intestinal absorption system. This allows plasma concentrations to be elevated to pharmacologic concentrations that are unachievable via oral administration.
When taken orally Vitamin C works as an anti-oxidant; however, when taken intravenously, Vitamin C now works as a pro-oxidant by generation of extracellular hydrogen peroxide (H2O2). What makes Intravenous Vitamin C unique is that it only targets cancer cells and does not negatively impact your normal, healthy cells. Patients receiving this therapy typically better tolerate the side effects of conventional treatments. Studies demonstrate the Intravenous Vitamin C enhances certain chemotherapeutics, something we also see clinically in the practice. Intravenous Vitamin C is a very safe and is very well tolerated.
